BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29024486)

  • 1. Development of locus specific sub-clone separation by fluorescence in situ hybridization in suspension in chronic lymphocytic leukemia.
    Do CH; Bailey S; Macardle C; Thurgood LA; Lower KM; Kuss BJ
    Cytometry A; 2017 Nov; 91(11):1088-1095. PubMed ID: 29024486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation.
    Yu L; Kim HT; Kasar S; Benien P; Du W; Hoang K; Aw A; Tesar B; Improgo R; Fernandes S; Radhakrishnan S; Klitgaard J; Lee C; Getz G; Setlur SR; Brown JR
    Clin Cancer Res; 2017 Feb; 23(3):735-745. PubMed ID: 27503198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13) in chronic lymphocytic leukemia. a study of 40 early-onset patients.
    Doneda L; Montillo M; Intropido L; Tedeschi A; Morra E; Larizza L
    Cancer Genet Cytogenet; 2003 Jan; 140(1):31-6. PubMed ID: 12550755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.
    Greipp PT; Smoley SA; Viswanatha DS; Frederick LS; Rabe KG; Sharma RG; Slager SL; Van Dyke DL; Shanafelt TD; Tschumper RC; Zent CS
    Br J Haematol; 2013 Nov; 163(3):326-33. PubMed ID: 24032430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The percentage of cells with 17p deletion and the size of 17p deletion subclones show prognostic significance in chronic lymphocytic leukemia.
    Yuan YY; Zhu HY; Wu JZ; Xia Y; Liang JH; Wu W; Cao L; Wang L; Fan L; Li JY; Xu W
    Genes Chromosomes Cancer; 2019 Jan; 58(1):43-51. PubMed ID: 30350431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing.
    Mohr J; Helfrich H; Fuge M; Eldering E; Bühler A; Winkler D; Volden M; Kater AP; Mertens D; Te Raa D; Döhner H; Stilgenbauer S; Zenz T
    Blood; 2011 Feb; 117(5):1622-32. PubMed ID: 21115975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trisomy 12 assessment by conventional fluorescence in-situ hybridization (FISH), FISH in suspension (FISH-IS) and laser scanning cytometry (LSC) in chronic lymphocytic leukemia.
    Do CH; Lower KM; Macardle C; Kuss BJ
    Cancer Genet; 2017 Oct; 216-217():142-149. PubMed ID: 29025588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation.
    Buccheri V; Barreto WG; Fogliatto LM; Capra M; Marchiani M; Rocha V
    Ann Hematol; 2018 Dec; 97(12):2269-2278. PubMed ID: 30315344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
    Fabris S; Mosca L; Todoerti K; Cutrona G; Lionetti M; Intini D; Matis S; Colombo M; Agnelli L; Gentile M; Spriano M; Callea V; Festini G; Molica S; Lambertenghi Deliliers G; Morabito F; Ferrarini M; Neri A
    Genes Chromosomes Cancer; 2008 Sep; 47(9):781-93. PubMed ID: 18521849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Immuno-flowFISH" for the Assessment of Cytogenetic Abnormalities in Chronic Lymphocytic Leukemia.
    Hui HYL; Clarke KM; Fuller KA; Stanley J; Chuah HH; Ng TF; Cheah C; McQuillan A; Erber WN
    Cytometry A; 2019 May; 95(5):521-533. PubMed ID: 31016848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study.
    Fabris S; Scarciolla O; Morabito F; Cifarelli RA; Dininno C; Cutrona G; Matis S; Recchia AG; Gentile M; Ciceri G; Ferrarini M; Ciancio A; Mannarella C; Neri A; Fragasso A
    Genes Chromosomes Cancer; 2011 Sep; 50(9):726-34. PubMed ID: 21638517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant nuclear p53 expression predicts hemizygous 17p (TP53) deletion in chronic lymphocytic leukemia.
    Chang H; Jiang AM; Qi CX
    Am J Clin Pathol; 2010 Jan; 133(1):70-4. PubMed ID: 20023260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterising the TP53-deleted subgroup of chronic lymphocytic leukemia: an analysis of additional cytogenetic abnormalities detected by interphase fluorescence in situ hybridisation and array-based comparative genomic hybridisation.
    Rudenko HC; Else M; Dearden C; Brito-Babapulle V; Jones C; Dexter T; Fenwick K; Mackay A; Ashworth A; Matutes E; Gonzalez D; Catovsky D; Morgan GJ
    Leuk Lymphoma; 2008 Oct; 49(10):1879-86. PubMed ID: 18949611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
    Dal Bo M; Rossi FM; Rossi D; Deambrogi C; Bertoni F; Del Giudice I; Palumbo G; Nanni M; Rinaldi A; Kwee I; Tissino E; Corradini G; Gozzetti A; Cencini E; Ladetto M; Coletta AM; Luciano F; Bulian P; Pozzato G; Laurenti L; Forconi F; Di Raimondo F; Marasca R; Del Poeta G; Gaidano G; Foà R; Guarini A; Gattei V
    Genes Chromosomes Cancer; 2011 Aug; 50(8):633-43. PubMed ID: 21563234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How best to manage patients with chronic lymphocytic leuekmia with 17p deletion and/or TP53 mutation?
    Tam CS; Stilgenbauer S
    Leuk Lymphoma; 2015 Mar; 56(3):587-93. PubMed ID: 25641428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 mutation and survival in chronic lymphocytic leukemia.
    Zenz T; Eichhorst B; Busch R; Denzel T; Häbe S; Winkler D; Bühler A; Edelmann J; Bergmann M; Hopfinger G; Hensel M; Hallek M; Döhner H; Stilgenbauer S
    J Clin Oncol; 2010 Oct; 28(29):4473-9. PubMed ID: 20697090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia.
    Dubuc AM; Davids MS; Pulluqi M; Pulluqi O; Hoang K; Hernandez-Sánchez JM; Schlich C; Hernández-Rivas JM; Brown JR; Dal Cin P
    Am J Hematol; 2016 Oct; 91(10):978-83. PubMed ID: 27341486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential fluorescence in situ hybridization analysis for trisomy 12 in B-cell chronic lymphocytic leukemia.
    Hjalmar V
    Methods Mol Med; 2005; 115():231-40. PubMed ID: 15998971
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Campo E; Cymbalista F; Ghia P; Jäger U; Pospisilova S; Rosenquist R; Schuh A; Stilgenbauer S
    Haematologica; 2018 Dec; 103(12):1956-1968. PubMed ID: 30442727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations.
    Rigolin GM; del Giudice I; Formigaro L; Saccenti E; Martinelli S; Cavallari M; Lista E; Tammiso E; Volta E; Lupini L; Bassi C; Bardi A; Sofritti O; Daghia G; Cavazzini F; Marinelli M; Tavolaro S; Guarini A; Negrini M; Foà R; Cuneo A
    Genes Chromosomes Cancer; 2015 Dec; 54(12):818-26. PubMed ID: 26355802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.